Astria Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Astria Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2024.
  • Astria Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $400K, a 100% increase year-over-year.
  • Astria Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $1M, a 42.9% increase year-over-year.
  • Astria Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $700K, a 12.5% decline from 2022.
  • Astria Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $800K, a 14.3% increase from 2021.
  • Astria Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $700K, a 53.3% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1M $400K +$200K +100% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $800K $300K +$100K +50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $700K $200K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $700K $100K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-04
Q3 2023 $700K $200K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $700K $200K -$100K -33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $800K $200K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $800K $100K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 $800K $200K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $800K $300K +$100K +50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $700K $200K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $700K $100K -$200K -66.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $900K $200K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $900K $200K -$300K -60% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.2M $200K -$300K -60% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.5M $300K -$100K -25% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.6M $200K -$200K -50% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.8M $500K +$200K +66.7% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.6M $500K +$200K +66.7% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $1.4M $400K Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-19
Q3 2019 $400K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $300K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $300K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.